Company patents
Tendyne Holdings, Inc.
Tendyne Holdings, Inc. exhibits a highly concentrated patent strategy, with 100.0% of its portfolio in Implants & Prosthetics, which surprisingly shows a consistent decline in patenting activity, with a -75.0% drop so far in 2026. Despite this, the company showed a brief emerging focus in Polymer Compositions and Sterilization & Biocompatible Materials in 2024-2025, with +100.0% and +50.0% YoY growth respectively, before a sharp decline in 2026, indicating a potential shift away from these areas.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
33 US filings (since 2023) · 5 categories · 4 themes
Implantable devices designed to repair, replace, or assist the function of blood vessels or heart structures, including stents, valves, and annuloplasty rings.
Engineering and material considerations for devices used in minimally invasive procedures, focusing on mechanical properties, deployment mechanisms, and interaction with biological tissues.
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Minimally invasive medical devices, typically flexible tubes, inserted into body lumens to deliver substances, remove obstructions, or perform localized treatments like ablation, dialysis, or drainage.
Patents
Showing 1-10 of 100